Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for insulin sensitivity in obese insulin-resistant adults
NL-OMON33714Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in insulin resistance (IR), cardiometabolic risk (CMR) and obesity comparing Anakinra with Placebo (2 arms). Primary endpoint: Insulin sensitivity. Started Mar 2009; status: active, not recruiting.
02
Drugs
anakinra
03
Conditions
insulin resistance (IR)cardiometabolic risk (CMR)obesity
Beyond the preview
Go deeper on NL-OMON33714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33714.